1. MicroRNA-195-3p promotes hepatic stellate cell activation and liver fibrosis by suppressing PTEN expression
   Ao Wang et al, 2022, Toxicology Letters CrossRef
2. Bone marrow mesenchymal stem cells-secreted exosomal microRNA-205–5p exerts inhibitory effect on the progression of liver cancer through regulating CDKL3
   Qin Sun et al, 2021, Pathology - Research and Practice CrossRef
3. MiR-195-3p is a Novel Prognostic Biomarker Associated with Immune Infiltrates of Lung Adenocarcinoma
   Yi Lao et al, 2022, International Journal of General Medicine CrossRef
4. Epigenetics in renal cell cancer: mechanisms and clinical applications
   Sophie C. Joosten et al, 2018, Nature Reviews Urology CrossRef
5. Six MicroRNA Prognostic Models for Overall Survival of Lung Adenocarcinoma
   Juan Li et al, 2022, Genetics Research CrossRef
6. MiR‐195 and miR‐497 suppress tumorigenesis in lung cancer by inhibiting SMURF2‐induced TGF‐β receptor I ubiquitination
   Dong‐Kyu Chae et al, 2019, Molecular Oncology CrossRef
7. MiR-195-3p inhibits cell proliferation in cervical cancer by targeting BCDIN3D
   Minfei Jin et al, 2021, Journal of Reproductive Immunology CrossRef
8. MicroRNA-195-3p inhibits cyclin dependent kinase 1 to induce radiosensitivity in nasopharyngeal carcinoma
   Fuchuan Xie et al, 2021, Bioengineered CrossRef
9. Long noncoding RNA TINCR facilitates hepatocellular carcinoma progression and dampens chemosensitivity to oxaliplatin by regulating the miR-195-3p/ST6GAL1/NF-κB pathway
   Jie Mei et al, 2022, Journal of Experimental & Clinical Cancer Research CrossRef
10. Unveiling massive numbers of cancer-related urinary-microRNA candidates via nanowires
    Takao Yasui et al, 2017, Science Advances CrossRef